Bicara Therapeutics Inc

NEW
NAS:BCAX (USA)  
$ 28.31 +1.44 (+5.36%) 11:31 AM EST
At Loss
P/B:
3.61
Market Cap:
$ 1.86B
Enterprise V:
$ 1.32B
Volume:
416.26K
Avg Vol (2M):
666.10K
Trade In:
Volume:
416.26K
At Loss
Avg Vol (2M):
666.10K

Bicara Therapeutics Inc (BCAX) Dividend

Bicara Therapeutics Inc (BCAX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: BCAX Dividend

Does Bicara Therapeutics Inc (BCAX) pay a dividend?

Bicara Therapeutics Inc (BCAX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Bicara Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Bicara Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -3% over the past 3 years.

What are dividend-paying alternatives to Bicara Therapeutics Inc?

For dividend-paying alternatives in Bicara Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.